The shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) started off the last trading session with the price of $0.66 while closing the day with the price of $0.67. The shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Rise 1.52% with the Gain of 0.01 points.
The shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) traded with the day volume of 861407 shares whereas its average trading volume is 897.06 Million.
While analyzing the past performance of the stock we can see that the shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Gain 6.35% in the last week while rising 3.94% in the last month. Past quarter performance shows the red light with -51.45%. The semi-annual and annual performance shows -65.64% and -75.55% respectively.
Some critical values of the shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) to be discussed here are: the beta which shows the value at -0.99 while Average True Range of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) demonstrate the value at 0.05. The weekly and monthly volatility of the shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) are indicated at 10.39% and 6.89%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 39.18.
While studying the financial position of the shares of Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), we can see that the Market capitalization of the company is at 10.66 Million. The shares outstanding for the company is 15.91 Million and the shares float stands at 11.45 Million. The income of the company stand at -6600000 while the sales stand at 0.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.59, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 0, the Return on Asset ROA stood at -0.77 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at 0.
Puma Biotechnology, Inc. (NASDAQ:PBYI)
Puma Biotechnology, Inc. (NASDAQ:PBYI) started its previous trading session at $80.75 and closed at $79.45 showing a Fell of -1.61 Percent.
The Company traded with an average Volume of 1 Million whereas, its Day Volume stood at 691554.
Looking at the performance of the stock, Puma Biotechnology, Inc. (NASDAQ:PBYI) Gain 4.13% in the last week in its shares price and 33.08% in the last month. Quarterly performance shows a red of -24.33 Percent while Semi-Annual and Annual performances shows a -23.79 and 98.38 percent respectively.
Beta for Puma Biotechnology, Inc. (NASDAQ:PBYI) stands at 0.12 while the ATR (average true range) is at 4.39. The Stock’s Weekly and Monthly Volatility is 4.70% and 6.90% respectively showing a RSI value of 58.34.
While studying the financial position of the shares of Puma Biotechnology, Inc. (NASDAQ:PBYI), we can see that the Market capitalization of the company is at 2.99 Billion. The shares outstanding for the company is 37.58 Million and the shares float stands at 32.5 Million.
The Company generated an income of -292000000 and the sales of 27.7 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-7.86 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 107.79 respectively.
The Return on Assets stands at -1.403, ROE shows a value of -2.006 and ROI for Puma Biotechnology, Inc. (NASDAQ:PBYI) is 0 as of Trailing Twelve Months period.
